Review Article

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases

Table 1

Ligands for PPAR .

Ligand classCompoundsReferences

Endogenous agonists15d-PGJ2, [122125]
13-Hydroxyoctadecadienoic acid (13-HODE),[122]
9-hydroxyoctadecadienoic acid (9-HODE),[122]
15-hydroxyeicosatetraenoic acid (15-HETE),[123]
nitrolinoleic acid[126]

Synthetic agonistsPioglitazone, troglitazone, rosiglitazone, ciglitazone, TZD18,[127129]
JTT-501, CDDO, SB-219994, SB-219993, GW2331, GW0072,[130133]
5-ASA, PAT5A, TAK-559, GW7845, GW1929, LG10074,[122, 134137]
indomethacin, ibuprofen, flufenamic acid, conjugated linoleic acid,[123, 138140]
L-764406, L-796449, LY-510929, LY-465608, AD-5061, AD-5075,[141144]
KRP-297/MK-0767, MCC555, ragaglitazar, farglitazar, diclofenac[145148]

AntagonistsGW9662, CDDO-Me, BADGE, PD068235, SR-202[149, 150]